Key Highlights

  • UnitedHealth (NYSE:UNH) rose 10.24% over one month to USD 414.91 in published market data as of October 28, 2026, and it is up 25.39% year to date, though flat over three months.
  • Third-quarter adjusted EPS reported on October 13, 2026 was USD 4.69 against USD 2.92 a year earlier, on revenue of USD 112.7 billion, slightly below USD 113.2 billion.
  • The medical care ratio improved to 88.4% from 89.9%, including USD 610 million of favorable prior-period reserve development related to 2026 dates of service. in the quarter.
  • The company raised its 2026 outlook to at least USD 20.50 of adjusted EPS, and at least 69% of Medicare Advantage members are in plans rated 4 stars or higher for 2027.

What the Company Reported on October 13

UnitedHealth (NYSE:UNH) reported third-quarter 2026 results on October 13, 2026. Revenue was USD 112.7 billion, down from USD 113.2 billion a year earlier, while adjusted EPS rose to USD 4.69 from USD 2.92 and GAAP diluted EPS was USD 4.56. The medical care ratio, the share of premiums paid out for care, fell to 88.4% from 89.9%. The full-year outlook was raised to at least USD 20.50 of adjusted EPS and at least USD 19.50 of GAAP EPS. Chief Executive Stephen Hemsley said results reflected the discipline and execution of the teams. Published market data showed the shares closed near USD 395.62 on October 15, 2026 after a 4.7% rise.

Quality of the Beat

Part of the improvement came from USD 610 million of favorable prior-period reserve development. That equals about 0.5 points of the medical care ratio, simple arithmetic on USD 610 million and USD 112.7 billion, so the underlying ratio was nearer 88.9%. Reserve releases can recur, but they are not operating improvement. The company also said its 2027 Medicare Advantage Stars results put at least 69% of members in plans rated 4 stars or higher, in line with expectations, and it expects further commitments in 2027, without specifying them in the figures retrieved. A reserve release means the company set aside more for past claims than it needed, and the excess flows into earnings. Investors therefore compare the reported ratio with the underlying figure when judging whether margin repair is durable. The 2027 outlook will be the clearer guide.

Risks and What to Watch

Revenue fell year over year, so the EPS gain came from cost control and margin repair, not growth. Care costs, regulation of Medicare Advantage and policy changes remain the main sector risks. The shares are flat over three months and fell 1.63% in the latest week as of October 28, 2026, so the monthly gain was concentrated around the report. Investors should watch whether the medical care ratio holds near 88% without reserve releases and what the company says about 2027. Policy is a further risk, because Medicare Advantage payment rules and star ratings drive revenue and margins for the sector, and any change in utilization trends can quickly alter the medical care ratio. After a 25.39% year-to-date gain, expectations are higher than they were before the report.

Where Things Stand

The answer is that UnitedHealth (NYSE:UNH) gained 10.24% because third-quarter results on October 13, 2026 showed adjusted EPS of USD 4.69, a lower medical care ratio and a raised outlook, which restored confidence after a difficult period. The quality caveat is a USD 610 million reserve release and falling revenue. At USD 414.91 as of October 28, 2026 the stock is up 25.39% this year but only flat over three months, so the next test is 2027 guidance and cost trends.